Rena Conti

Rena Conti is an Associate Professor at the Questrom School of Business, Boston University, focusing on pharmaceutical policy, health economics, and prescription drug affordability. Her research addresses financial toxicity, drug pricing regulation, and pharmaceutical supply chain dynamics.

• Education: PhD in Health Economics (Harvard University), AB in Economics (Princeton University)
• Research Areas: Prescription drug policy, health economics, financial barriers in cancer care, and pharmaceutical supply chain resilience.

Her recent articles examine Covid-19 drug stockpiling, 340B program impacts, Medicare drug negotiation, and gene therapy cost modeling. These works span pharmaceutical economics, public health policy, and clinical oncology finance.

She has contributed to understanding financial hardship in cancer survivors, opioid prescription trends, and 340B drug pricing through collaborations with multidisciplinary teams. Her work informs Medicare reform, generic drug policies, and equitable healthcare access.